Capella 4055 Assessment 4

Name

Capella university

NURS-FPX4055 Optimizing Population Health through Community Practice

Prof. Name

Date

Health Promotion Plan Presentation

Welcome, and thank you for joining today’s health session. Our focus is on preventing Human Papillomavirus (HPV) infections in adolescents and young adults aged 11 to 26 residing in Schwenksville, Pennsylvania. This session outlines essential knowledge about HPV, its cancer associations, and the significance of timely vaccination. It also introduces effective strategies for initiating conversations with healthcare providers and family members about the HPV vaccine. The content presented is aligned with SMART goals previously developed in collaboration with stakeholders and adheres to the objectives outlined by Healthy People 2030.

Presentation Roadmap

This presentation will guide participants through the following objectives:

• Present critical facts regarding HPV, how it spreads, and its role in cancer development.
• Clarify the safety, necessity, and benefits of HPV immunization.
• Motivate participants to schedule the HPV vaccine within the next 30 days.
• Strengthen participants’ abilities to discuss HPV vaccination confidently with both family and healthcare providers.
• Use interactive segments to foster engagement and deepen understanding.
• Conclude with an evaluation of knowledge retention and confidence levels through a brief post-session quiz and survey.

Key Information About HPV and Cancer Risk

HPV is a prevalent virus transmitted mainly through sexual contact and skin-to-skin interaction. The full vaccination rate among adolescents in Pennsylvania is only 68.7%, with rural areas like Schwenksville demonstrating even lower rates—around 48.7% (PA.gov, 2025). These lower vaccination rates contribute to heightened cancer incidence and mortality in rural communities.

HPV can lead to various cancers, including cervical, anal, throat, and genital cancers. The virus’s high-risk strains, especially HPV types 16 and 18, can remain asymptomatic yet persist long enough to cause cellular changes leading to cancer (Huber et al., 2021). Vaccination is a key preventive measure, significantly reducing the risk of long-term HPV infections and cancer. Routine screenings also remain essential to detect early cellular changes.

Benefits of Timely HPV Vaccination

Administering the HPV vaccine at the recommended age of 11–12 offers long-term protection. Early vaccination allows the immune system to mount a robust and lasting response (Hoes et al., 2021). Immunization before virus exposure ensures optimal efficacy.

Cervical cancer remains the second most prevalent cancer in women globally. Timely vaccination prevents the strains that cause most cases of this disease (Huber et al., 2021). Additionally, the vaccine helps prevent other HPV-related cancers in men and women, such as anal, penile, and oropharyngeal cancers (Cheng et al., 2020).

The vaccine also protects against genital warts, which can cause physical discomfort and emotional distress. Early vaccination not only offers individual protection but also supports community immunity. As more people receive the vaccine, HPV transmission rates decline, creating a protective barrier for those who cannot be vaccinated (Xu et al., 2024).

Strategies for HPV Vaccine Communication

Effective communication is essential in advocating for HPV vaccination. Several strategies include:

• Using Reliable Sources: Share facts and statistics from credible organizations like the CDC or WHO to support the vaccine’s effectiveness and safety.
• Asking Insightful Questions: Encourage dialogue through informed questions, such as the long-term effects of the vaccine or its cancer prevention benefits (Kassymbekova et al., 2023).
• Debunking Myths: Address vaccine misinformation calmly and factually. For instance, explain that the vaccine prevents cancer rather than promoting early sexual behavior.

SMART Goals Developed with Participants

This session is structured around SMART goals collaboratively developed with attendees:

1. By session end, 90% of participants will identify at least three essential facts about HPV and its cancer links, measured via a quiz.
2. At least 80% will commit to scheduling their first HPV vaccine dose within 30 days using provided resources.
3. Around 85% will feel more confident discussing the vaccine with family and healthcare providers through practiced conversations.

These goals aim to empower individuals with knowledge and action to support both personal and community health.

Evaluation of SMART Goal Outcomes

The session outcomes were largely successful in meeting established SMART goals:

SMART Goal	Target Outcome	Actual Outcome	Comments
Identify 3 key HPV facts	90%	92.5%	Achieved through interactive quiz
Commit to scheduling vaccine	80%	75%	Slightly missed; family hesitations noted
Confidence in discussing vaccine	85%	85%	Met; role-play helped improve comfort

Some adolescent participants hesitated to commit to vaccination without family input. Additionally, a few attendees expressed uncertainty about addressing myths. Future improvements include integrating real-time family discussions, enhancing role-playing activities, and offering extended or follow-up sessions to reinforce learning and decision-making.

Evaluation Based on Healthy People 2030 Objectives

The session aligns well with Healthy People 2030’s aims to reduce HPV-related cancer cases by increasing adolescent vaccination rates. Participants showed marked improvement in knowledge (92.5%) and discussion confidence (85%), reflecting the program’s effectiveness in raising awareness and empowering informed decision-making.

However, the 75% commitment rate to vaccine initiation fell slightly short of the 80% target. Some attendees remained skeptical about vaccine safety. To enhance future alignment with Healthy People 2030, program modifications could include more thorough discussions on vaccine efficacy, engaging families earlier, and offering credible safety data to dispel myths (Xu et al., 2024). These enhancements could lead to improved vaccine acceptance and trust among hesitant groups.

Conclusion

In conclusion, promoting HPV vaccination among adolescents and young adults in Schwenksville, PA, is vital to reducing future cancer risks. This educational effort demonstrated the value of early immunization, open communication, and informed health advocacy. While the session effectively increased knowledge and confidence, there are opportunities to improve commitment and myth-busting capabilities. Through continued community education, we move closer to fulfilling the Healthy People 2030 vision for a healthier, better-informed population.

---

References

Cheng, L., Wang, Y., & Du, J. (2020). Human papillomavirus vaccines: An updated review. Vaccines, 8(3), 391. https://doi.org/10.3390/vaccines8030391

Hoes, J., Pasmans, H., Schurink-van ’t Klooster, T. M., van der Klis, F. R. M., Donken, R., Berkhof, J., & de Melker, H. E. (2021). Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge. Human Vaccines & Immunotherapeutics, 18(1). https://doi.org/10.1080/21645515.2021.1908059

Capella 4055 Assessment 4

Huber, J., Mueller, A., Sailer, M., & Regidor, P.-A. (2021). Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Women’s Health, 17, 174550652110207. https://doi.org/10.1177/17455065211020702

Kassymbekova, F., Zhetpisbayeva, I., Tcoy, E., Dyussenov, R., Davletov, K., Rommel, A., & Glushkova, N. (2023). Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: A mixed-methods study protocol. BMJ Open, 13(9), e074097. https://doi.org/10.1136/bmjopen-2023-074097

PA.gov. (2025). Dear VFC provider. https://www.pa.gov/content/dam/copapwp-pagov/en/health/documents/topics/documents/programs/immun…

Capella 4055 Assessment 4

U.S. Department of Health and Human Services. (n.d.). Healthy People 2030 Objectives. https://health.gov/healthypeople